Assessment of 2-year outcome between calcium phosphate-hybridized vs untreated STG autograft in ACLR .
Anatomic single-bundle anterior cruciate ligament reconstruction using a calcium phosphate-hybridized tendon graft: a randomized controlled trial with 2 years of follow-up
J Orthop Surg Res. 2018 Dec 29;13(1):327. doi: 10.1186/s13018-018-1045-190 patients scheduled for anterior cruciate ligament reconstruction with a hamstring autograft were randomized to either have the ends of the graft treated with calcium chloride and sodium phosphate solutions for calcium phosphate hybridization (CaP group), or to no treatment of the graft. Patients were assessed on CT scans for increase in cross-sectional area of the femoral and tibial bone tunnels to measure bone tunnel enlargement, as well as for the incidence of rerupture, objective and subjective knee laxity measures, and knee function scores. Follow-up was performed at 1 and 2 years postoperatively. The only significant difference observed between groups was in the increase in cross-sectional area of the femoral tunnel after 1 year, which was lower in the CaP group; the difference between groups at 2 years was not significant. In addition, no significant differences between groups were observed in tibial tunnel enlargement, rerupture rate, KT-1000 arthrometer results, pivot-shift test result, International Knee Documentation Committee grading, Lysholm score, or Tegner activity scale grading.
Desbloquear el informe ACE completo
Tiene acceso a 4 más artículos GRATUITOS este mes.
Haga clic a continuación para desbloquear y ver este ACE Reports
Desbloquear ahora
Evaluaciones críticas de los últimos ensayos controlados aleatorizados de gran impacto y revisiones sistemáticas en ortopedia
Acceso al contenido del podcast OrthoEvidence, que incluye colaboraciones con el Journal of Bone and Joint Surgery, entrevistas con cirujanos reconocidos internacionalmente y mesas redondas sobre noticias y temas ortopédicos
Suscripción a The Pulse, un boletín quincenal basado en la evidencia y diseñado para ayudarle a tomar mejores decisiones clínicas
Acceso exclusivo a artículos de contenido original, incluidas revisiones sistemáticas propias, y artículos sobre métodos de investigación sanitaria y temas ortopédicos de actualidad
O actualícese hoy mismo y obtenga acceso a todo el contenido de OrthoEvidencepor tan sólo 1,99 $ a la semana.
¿Ya tiene una cuenta? Conectarse
Suscríbase a "El Pulso"
Ortopedia basada en la evidencia directamente a su bandeja de entrada. SUSCRIBIRSE